Wells Fargo’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $313K | Buy |
62,167
+5,735
| +10% | +$28.9K | ﹤0.01% | 4099 |
|
|
2025
Q1 | $366K | Buy |
56,432
+3,771
| +7% | +$24.4K | ﹤0.01% | 3865 |
|
|
2024
Q4 | $387K | Sell |
52,661
-199,096
| -79% | -$1.46M | ﹤0.01% | 3884 |
|
|
2024
Q3 | $1.89M | Buy |
251,757
+209,341
| +494% | +$1.57M | ﹤0.01% | 2795 |
|
|
2024
Q2 | $378K | Buy |
42,416
+12,620
| +42% | +$112K | ﹤0.01% | 3744 |
|
|
2024
Q1 | $302K | Buy |
29,796
+3,771
| +14% | +$38.2K | ﹤0.01% | 3863 |
|
|
2023
Q4 | $262K | Sell |
26,025
-90,443
| -78% | -$910K | ﹤0.01% | 3925 |
|
|
2023
Q3 | $1.09M | Buy |
116,468
+26,028
| +29% | +$244K | ﹤0.01% | 3028 |
|
|
2023
Q2 | $2.22M | Buy |
90,440
+20,313
| +29% | +$498K | ﹤0.01% | 2678 |
|
|
2023
Q1 | $1.63M | Buy |
70,127
+63,824
| +1,013% | +$1.49M | ﹤0.01% | 2845 |
|
|
2022
Q4 | $160K | Sell |
6,303
-5,060
| -45% | -$128K | ﹤0.01% | 4019 |
|
|
2022
Q3 | $219K | Sell |
11,363
-1,385
| -11% | -$26.7K | ﹤0.01% | 3927 |
|
|
2022
Q2 | $325K | Sell |
12,748
-29,471
| -70% | -$751K | ﹤0.01% | 3777 |
|
|
2022
Q1 | $1.09M | Sell |
42,219
-17,963
| -30% | -$462K | ﹤0.01% | 3587 |
|
|
2021
Q4 | $2.52M | Sell |
60,182
-377
| -0.6% | -$15.8K | ﹤0.01% | 3056 |
|
|
2021
Q3 | $2.64M | Buy |
60,559
+42,761
| +240% | +$1.86M | ﹤0.01% | 3266 |
|
|
2021
Q2 | $842K | Sell |
17,798
-4,711
| -21% | -$223K | ﹤0.01% | 4080 |
|
|
2021
Q1 | $1.15M | Sell |
22,509
-77,602
| -78% | -$3.98M | ﹤0.01% | 3897 |
|
|
2020
Q4 | $2.68M | Buy |
100,111
+58,771
| +142% | +$1.57M | ﹤0.01% | 3243 |
|
|
2020
Q3 | $1.42M | Sell |
41,340
-26,294
| -39% | -$902K | ﹤0.01% | 3532 |
|
|
2020
Q2 | $2.77M | Buy |
67,634
+55,674
| +466% | +$2.28M | ﹤0.01% | 2966 |
|
|
2020
Q1 | $410K | Buy |
11,960
+11,373
| +1,937% | +$390K | ﹤0.01% | 4058 |
|
|
2019
Q4 | $7K | Buy |
+587
| New | +$7K | ﹤0.01% | 5627 |
|